1. Home
  2. RXST vs AIP Comparison

RXST vs AIP Comparison

Compare RXST & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXST
  • AIP
  • Stock Information
  • Founded
  • RXST 1997
  • AIP 2003
  • Country
  • RXST United States
  • AIP United States
  • Employees
  • RXST N/A
  • AIP N/A
  • Industry
  • RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AIP Semiconductors
  • Sector
  • RXST Health Care
  • AIP Technology
  • Exchange
  • RXST Nasdaq
  • AIP Nasdaq
  • Market Cap
  • RXST 385.0M
  • AIP 412.9M
  • IPO Year
  • RXST 2021
  • AIP 2021
  • Fundamental
  • Price
  • RXST $8.35
  • AIP $13.01
  • Analyst Decision
  • RXST Hold
  • AIP Strong Buy
  • Analyst Count
  • RXST 11
  • AIP 3
  • Target Price
  • RXST $11.80
  • AIP $15.00
  • AVG Volume (30 Days)
  • RXST 792.1K
  • AIP 682.1K
  • Earning Date
  • RXST 11-06-2025
  • AIP 11-04-2025
  • Dividend Yield
  • RXST N/A
  • AIP N/A
  • EPS Growth
  • RXST N/A
  • AIP N/A
  • EPS
  • RXST N/A
  • AIP N/A
  • Revenue
  • RXST $147,059,000.00
  • AIP $63,236,000.00
  • Revenue This Year
  • RXST N/A
  • AIP $19.05
  • Revenue Next Year
  • RXST $6.71
  • AIP $17.96
  • P/E Ratio
  • RXST N/A
  • AIP N/A
  • Revenue Growth
  • RXST 27.68
  • AIP 18.64
  • 52 Week Low
  • RXST $6.32
  • AIP $5.46
  • 52 Week High
  • RXST $55.57
  • AIP $14.58
  • Technical
  • Relative Strength Index (RSI)
  • RXST 42.47
  • AIP 77.06
  • Support Level
  • RXST $8.55
  • AIP $9.67
  • Resistance Level
  • RXST $9.39
  • AIP $10.75
  • Average True Range (ATR)
  • RXST 0.48
  • AIP 0.68
  • MACD
  • RXST -0.10
  • AIP 0.32
  • Stochastic Oscillator
  • RXST 1.40
  • AIP 81.90

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

About AIP Arteris Inc.

Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.

Share on Social Networks: